Table 2 –
Analysis variable: Sex
| Group | N Obs | Female | Male |
|---|---|---|---|
| Healthy | 49 | 25 (51.02%) | 24 (48.98%) |
| Melanoma | 49 | 25 (51.02%) | 24 (48.98%) |
| Stage 0 | 5 | 4 (80.00%) | 1 (20.00%) |
| Stage I | 18 | 11 (61.11%) | 7 (38.89%) |
| Stage II | 10 | 5 (50.00%) | 5 (50.00%) |
| Stage III | 6 | 3 (50.00%) | 3 (50.00%) |
| Stage IV | 10 | 2 (20.00%) | 8 (80.00%) |